Athyrium Capital Management
-
Malvern’s Recro Pharma Secures Nine-Figure Line of Credit
Malvern’s Recro Pharma has secured a line of credit worth $100 million from funds managed by Athyrium Capital Management, writes John George for the Philadelphia…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
